Homotypic and heterotypic immune responses to group A rotaviruses in parenterally immunized sheep.
Immune responses to human rotaviruses were investigated in sheep with a view to obtaining antibodies for passive immunotherapy of humans. Eighteen adult sheep with previous natural exposure to rotavirus serotypes G3 and G6 were immunized parenterally with purified preparations of either individual rotavirus serotypes G1, G2, G3, G4 and G8, or a mixture thereof. Two additional sheep were kept as control animals with the flock. The antibody responses were measured on serial serum samples by neutralization tests. The homotypic antibody response ranged from 100-fold (rarely) up to 100,000-fold increases in titre. Heterotypic responses against serotypes G3 and G6 were demonstrated in 7/12 and 15/18 sheep, respectively, but the increases in titre were lower than the homotypic responses, ranging from 10- to 100-fold in most cases and were 1000-fold in two sheep. Interestingly, no heterotypic response against the human rotavirus serotypes was raised after 3 months; moderate titres of cross-neutralizing antibodies for the human serotypes were only observed after a third inoculation.
Regional Virus Laboratory, East Birmingham Hospital, UK.
G M
GM
Beards
J A
JA
King
S
S
Mazhar
J
J
Landon
U
U
Desselberger
D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis* / Q000276:immunology; D000918:Antibody Specificity; D000956:Antigens, Viral; D002213:Capsid / Q000276:immunology*; D036022:Capsid Proteins; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D009500:Neutralization Tests; D012401:Rotavirus / Q000145:classification / Q000276:immunology*; D012756:Sheep / Q000276:immunology*; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000276:immunology; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology*
D000914:Antibodies, Viral; D000956:Antigens, Viral; D036022:Capsid Proteins; C060339:VP4 protein, Rotavirus; C050779:VP7 protein, Rotavirus; D014613:Vaccines, Attenuated; D014765:Viral Vaccines